Capital One Financial Corporation reported net income of $1.1 billion or $1.87 per diluted share in the second quarter of 2013, compared with $1.0 billion or $1.79 per diluted share last quarter, and $92 million in second-quarter 2012. Last year’s results reflected significant purchase accounting impacts as Capital One closed the acquisition of HSBC U.S. card business. The largest impact was the larger loan loss … Continue reading COF Sailing Along Into Q3
Leerink Swann initiated coverage on shares of Clovis Oncology (NASDAQ:CLVS) in a research report released on Friday morning. The firm issued an outperform rating and a $100.00 price objective on the stock. Clovis Oncology, Inc. (NASDAQ:CLVS) belongs to Healthcare sector. Its weekly performance is 11.49%. On last trading day company shares ended up $48.61. Clovis Oncology, Inc. (NASDAQ:CLVS) distance from 50-day simple moving average (SMA50) is 20.42%. … Continue reading Hot News: Clovis Oncology (NASDAQ:CLVS), Nokia Corporation (ADR) (NYSE:NOK), Key Technology (NASDAQ:KTEC), The First Bancorp (NASDAQ:FNLC), Capital One Financial (NYSE:COF)
